TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the $350 million European vascular access device market will grow slowly through 2016. Noticeable growth will result from the substitution of premium priced safety short peripheral intravenous catheters (PIVCs) and safety Huber needles for their cheaper standard alternatives, driven by the adoption of the EU Sharps Directive.
Safety short PIVCs will account for the largest revenue share in the European PIVC market, increasing from 69 percent in 2011 to 81 percent of the total by 2016, as they are increasingly adopted over standard short PIVCs because they reduce needlestick injuries. Growth in safety short PIVC sales will be slower in Germany and Spain because they adopted country-specific implementation guidelines early and market penetration is already quite high. France and Italy still lack national policies and will see slower adoption. The United Kingdom lacks a national guideline, but awareness of the directive has led to high unit sales and moderate market growth.
Safety Huber needles also help protect clinicians from needlestick injuries. Safety Huber needles come equipped with features, varying by manufacturer, that protect clinicians from accidental contact with the tip of the needle. The EU Sharps Directive calls for the adoption of safety needles by 2013. As with PIVCs, safety Huber needles are currently most widely used in Germany and Spain.
“Overall, safety device usage will expand across all European countries,” said MRG Senior Analyst Julie McLaughlin. “Safety PIVCs are sold at a price approximately 1.5 times higher than standard PIVCs, so their increased adoption will drive market revenue growth within the PIVC market.”
Millennium Research Group’s European Markets for Vascular Access Devices 2012 report includes procedure, unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for short peripheral intravenous catheters (PIVCs), central venous catheters (CVCs), implantable ports, dialysis catheters and peripherally inserted central catheters (PICCs) sold in France, Germany, Italy, Spain and the United Kingdom.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.